Home › Funds › Soleus Capital Management, L.P. › NVCT
Soleus Capital Management, L.P. position in NVCT
NUVECTIS PHARMA INC COM · Health Care
Soleus Capital Management, L.P. reported holding 1,000,000 shares of NVCT (NUVECTIS PHARMA INC COM) in its Q2 2026 13F filing — a position valued at US$18.4M, representing 0.63% of its reported portfolio and ranking #42 among its reported holdings. Soleus Capital Management, L.P. first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Soleus Capital Management, L.P.'s NVCT position evolved
Soleus Capital Management, L.P. first disclosed a stake in NVCT in Q2 2026 at 1,000,000 shares (US$18.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.00M | $18.39M | New |
About NVCT and 13F data
NVCT (NUVECTIS PHARMA INC COM) is a Health Care company. 61 other funds we track also report a position in NVCT — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$28.5M), IRIDIAN ASSET MANAGEMENT LLC/CT (US$14.3M), BALDWIN WEALTH PARTNERS LLC/MA (US$8.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVCT
- TANG CAPITAL MANAGEMENT LLC 1.55M sh · $28.50M · Q2 2026
- IRIDIAN ASSET MANAGEMENT LLC/CT 777.08K sh · $14.29M · Q2 2026
- BALDWIN WEALTH PARTNERS LLC/MA 382.01K sh · $8.07M · Q3 2026
- SPHERA FUNDS MANAGEMENT LTD. 382.94K sh · $7.04M · Q2 2026
- Occam Crest Management LP 4.80K sh · $5.16M · Q2 2026
- Avidity Partners Management LP 200.00K sh · $3.68M · Q2 2026
- Kalehua Capital Management LLC 100.00K sh · $1.84M · Q2 2026
- Squadron Capital Management LLC 38.70K sh · $711.69K · Q2 2026
More on Soleus Capital Management, L.P.
FAQ
How long has Soleus Capital Management, L.P. held NVCT?
Soleus Capital Management, L.P. has disclosed NVCT holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Soleus Capital Management, L.P.'s current position in NVCT?
As of Q2 2026, Soleus Capital Management, L.P. holds 1.00M shares of NVCT (NUVECTIS PHARMA INC COM), valued at $18.39M, representing 0.63% of its reported portfolio and ranking #42.
Has Soleus Capital Management, L.P. been buying or selling NVCT?
In the latest 13F filing (Q2 2026), Soleus Capital Management, L.P. newly opened its position in NVCT.
Which other funds hold NVCT?
Other major institutional holders of NVCT include TANG CAPITAL MANAGEMENT LLC, IRIDIAN ASSET MANAGEMENT LLC/CT, BALDWIN WEALTH PARTNERS LLC/MA, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.